AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Sitaglo M Forte Tablet

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitaglo M Forte Tablet

Combiforte-DM is a dual-action tablet managing elevated blood glucose in type 2 diabetes patients. This helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. Combiforte-DM may be used independently or alongside other diabetic treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health, glucose readings, and current medications. Consuming it with food minimizes stomach upset. Consistent daily use, at the same time, maximizes effectiveness; discontinue only under physician guidance. Adherence to your doctor's dietary and exercise plan is crucial. Lifestyle significantly impacts diabetes control. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Low blood sugar (hypoglycemia) is a possible adverse effect, especially with concurrent insulin or sulfonylurea use; learn hypoglycemia recognition and management. This medication isn't for everyone. Inform your physician of any prior kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before starting. Pregnant or lactating individuals should seek medical advice prior to use. Other medications may interact; disclose all medications to your doctor for safety. Alcohol should be minimized due to its blood glucose-lowering effect. Your doctor will monitor kidney function and blood sugar levels throughout treatment.

Primary Ingredients of Sitaglo M Forte Tablet

No text was provided. Please provide the text you wish me to rephrase.

Uses of Sitaglo M Forte Tablet

Managing type 2 diabetes

Major Benefits of Sitaglo M Forte Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitaglo M Forte Tablet with a meal.

Common Side effects of Sitaglo M Forte Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaglo M Forte Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer Sitaglo M Forte Tablet with a meal.

How Sitaglo M Forte Tablet works:

Sitaglo M Forte Tablets combine sitagliptin and metformin to effectively manage blood sugar. Sitagliptin boosts insulin production by the pancreas, enhances the body's insulin utilization, and lessens the liver's glucose output. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitaglo M Forte Tablet with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitaglo M Forte Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Employing Sitaglo M Forte Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaglo M Forte Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Sitaglo M Forte Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitaglo M Forte Tablet :

Should you forget a Sitaglo M Forte Tablet dose, administer it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaglo M Forte Tablet

LabelValue
Potential for Dependence None.
Medication Category Medication for diabetes

FAQs on Sitaglo M Forte Tablet

Sitaglo M Forte tablets contain sitagliptin and metformin, working together to manage type 2 diabetes in adults. This medication helps control blood sugar when used with a healthy diet and regular physical activity. Metformin reduces glucose production by the liver and enhances insulin sensitivity. Sitagliptin blocks the DPP4 enzyme, boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Prolonged Sitaglo M Forte Tablet use can indeed lead to vitamin B12 deficiency by hindering its absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may manifest as anemia and neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive strategies proposed by some researchers involve supplemental vitamin B12 intake at least annually.
Sitaglo M Forte Tablet may cause common side effects including low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitaglo M Forte Tablet ingredient or inactive component should not use this medication. This medicine is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitaglo M Forte Tablet is unsafe due to a heightened risk of lactic acidosis.
Maintain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Ensure its inaccessibility to children, pets, and other individuals.
Lactic acidosis, a serious medical condition resulting from excessive blood lactic acid, is a potential complication of Sitaglo M Forte Tablet. This adverse reaction, also termed Metformin-associated lactic acidosis (MALA), is infrequent but necessitates caution. Its occurrence is heightened in patients with compromised kidney function, advanced age, or significant alcohol consumption; hence, metformin is contraindicated in such individuals. Symptoms may present as muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms develop, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitaglo M Forte Tablets contain sitagliptin and metformin, working together to manage type 2 diabetes in adults. This medication helps regulate blood sugar when combined with a healthy diet and exercise regimen. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin blocks DPP4, promoting increased insulin secretion from the pancreas. This formulation is unsuitable for individuals under the age of 18.
Sitaglo M Forte Tablet may cause common side effects including low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal discomfort, loose stools, headache, and upper respiratory infections. Rare but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged use can result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitaglo M Forte Tablet constituents or inactive ingredients should not use this medication. Similarly, its use is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglo M Forte Tablet with alcohol is unsafe and may heighten the risk of developing lactic acidosis.
Sitaglo M Forte Tablet use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is a rare but significant adverse effect of metformin, prompting avoidance in individuals with kidney impairment, the elderly, or those consuming substantial alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. If such symptoms arise, discontinue Sitagliptin + Metformin immediately and seek urgent medical attention.
Prolonged Sitaglo M Forte Tablet use can indeed lead to vitamin B12 deficiency by hindering its absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may result in anemia and neurological complications. Symptoms can include paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures proposed by some studies include annual supplemental vitamin B12 intake.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines printed on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Sitaglo M Forte Tablets contain sitagliptin and metformin, working together to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Metformin reduces liver glucose production and improves insulin responsiveness. Sitagliptin blocks DPP-4, thereby boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Sitaglo M Forte Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious adverse effects such as lactic acidosis can occur. Prolonged use might result in vitamin B12 deficiency.
Patients with a history of hypersensitivity to Sitaglo M Forte Tablet constituents or inactive ingredients should not use this medication. This medicine is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglo M Forte Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitaglo M Forte Tablet use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This is also called Metformin-associated lactic acidosis (MALA). While infrequent, this side effect necessitates caution in patients with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms such as muscle aches, weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia warrant immediate discontinuation of Sitagliptin + Metformin and prompt medical attention.
Prolonged Sitaglo M Forte Tablet use can indeed lead to vitamin B12 deficiency due to impaired stomach absorption of the vitamin. This deficiency, if left unaddressed, may result in anemia and neurological complications, potentially manifesting as tingling or numbness in extremities, muscle weakness, urinary dysfunction, cognitive changes, and balance difficulties (ataxia). Preventive measures suggested by some studies include supplemental vitamin B12 intake at least annually.
Maintain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and other individuals.
Sitaglo M Forte Tablet
162
MRP 188
13% off